Biostatistics Intern
Alexion
Biostatistics Intern
Alexion
Global biopharmaceuticals focusing on rare diseases
Alexion is seeking a Biostatistics Intern to support the Quantitative Sciences organization at its Boston-Seaport, Massachusetts location. The PhD intern will work on a specialized short-term project supporting capability builds or key business initiatives, including using AI tools to develop a statistical application, conducting a simulation study to evaluate design characteristics, and presenting the work at a departmental seminar.
Date Posted
12-Nov-2026Closing Date
29-Nov-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion